Dr. Sioned Fôn Jones is a co-founder and Chief Operating Officer of BoobyBiome, a pioneering biotech start-up focused on leveraging the properties of the breast milk microbiome to enhance infant health. With a strong educational background in Chemistry and Biophysics from the University of Liverpool and King’s College London, she has made significant strides in scientific research, particularly concerning infants' gut health. Dr. Jones and her colleagues at BoobyBiome are at the forefront of developing innovative solutions to improve formula-fed babies' health by ensuring they benefit from beneficial bacteria typically found in breast milk.
Recent years have seen significant advancements and milestones in Dr. Sioned Jones' career and BoobyBiome's growth:
Attribute | Information |
---|---|
Full Name | Dr. Sioned Fôn Jones |
Born | (Exact Date: Not Available) |
Nationality | British |
Occupation | Scientist, Entrepreneur |
Known For | Co-founding BoobyBiome |
Net Worth | Not Publicly Disclosed |
Education | PhD in Biophysics, M.Sc. Chemistry |
Dr. Sioned Jones was raised in an environment that fostered her interest in the sciences. Encouraged by supportive parents and inspired by an influential chemistry teacher during her formative years, she pursued a path in Chemistry. She graduated from the University of Liverpool with first-class honors in Chemistry in 2017. Furthering her expertise, she completed a PhD in Biophysics at King's College London in 2022, where she honed her skills in interdisciplinary scientific research, focusing on the development of DNA-based nanotools to measure cellular membrane properties.
After obtaining her PhD, Dr. Sioned Jones co-founded BoobyBiome in 2019 alongside Dr. Lydia Mapstone and Dr. Tara O'Driscoll. Driven by a shared vision to address the global issues stemming from inadequate microbiome development in infants, they embarked on groundbreaking research into the breast milk microbiome:
Currently, Dr. Jones is dedicated to her role at BoobyBiome, where she is instrumental in developing both a storage device to preserve the natural microbiome in breast milk and innovative microbiome supplements for formula-fed infants. Her work aims to ensure that infants who cannot be breastfed have access to the same benefits as those who can. Through her efforts, BoobyBiome is establishing a new standard in infant nutrition and health, emphasizing the importance of conducive early gut development for long-term health outcomes.
Dr. Sioned Jones has significantly impacted the field of microbiome research, particularly in infant health. Her efforts have led to pioneering technologies that aim to provide equitable health opportunities for all newborns, regardless of their feeding choices. As she continues her groundbreaking work with BoobyBiome, Dr. Jones is poised to influence not only the field of biotechnology but also the broader scope of public health policy and practice, laying a foundation for healthier future generations.